Tocilizumab Aazg Concentrate

3 indexed presentations.

Reference only for licensed healthcare facilities. These listings support NDC-level identification and quote review, and do not imply current stock, manufacturer sponsorship, or direct purchasing status. Review NDC-level listings, compare package configurations, and request a quote review when needed.

Need a Product Not Listed?

Submit a quote review for unlisted NDCs, item codes, or alternate product presentations.

Drug Directory A-Z | Drug names: T | Drug Search | Request a Quote Review

Generic details

Review dosage forms, strengths, package variations, and manufacturer identifiers associated with Tocilizumab Aazg Concentrate.

  • Indexed presentation count: 3 indexed presentations.
  • Common dosage forms: Injection.

Common presentations

Compare presentation differences here, then open the table rows below for NDC-level confirmation.

  • Strength variation: 200 mg / 10mL, 400 mg / 20mL, and 80 mg / 4mL.
  • Package variation: 1 Vial, Single-Dose.
  • Manufacturer information is shown for product identification only.

Official references

Use official label-search references for this generic family when your team needs supplemental labeling context.

Showing page 1 of 1
Tyenne - Tocilizumab-aazg Concentrate 200 mg / 10mL Injection 10 mL65219-0592-10200 mg / 10mLInjection1 Vial, Single-Dose
Tyenne - Tocilizumab-aazg Concentrate 400 mg / 20mL Injection 20 mLPRN Watchlist65219-0594-20400 mg / 20mLInjection1 Vial, Single-Dose
Tyenne - Tocilizumab-aazg Concentrate 80 mg / 4mL Injection 4 mL65219-0590-0480 mg / 4mLInjection1 Vial, Single-Dose

Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.